The treatment of acyclovir-resistant herpes zoster with trifluorothymidine and interferon alfa.
Rossi
S
S
University of British Columbia, Vancouver.
Whitfeld
M
M
Berger
T G
TG
D000212:Acyclovir / Q000627:therapeutic use*; D000287:Administration, Topical; D003131:Combined Modality Therapy; D004352:Drug Resistance, Microbial; D006562:Herpes Zoster / Q000628:therapy*; D006801:Humans; D015552:Injections, Intralesional; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins; D017193:Skin Diseases, Viral / Q000628:therapy*; D016896:Treatment Outcome; D014271:Trifluridine / Q000627:therapeutic use*
D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D014271:Trifluridine; D000212:Acyclovir